- Home
- CHE
CHE
Chemed Corp
as 10-28-2025 9:33am EST
Chemed Corp purchases, operates, and divests subsidiaries engaged in diverse business activities to maximize shareholder value. Through its subsidiaries, the company operates in the following segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue and provides hospice and palliative care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers.
| Founded: | 1970 | Country: | United States |
| Employees: | N/A | City: | CINCINNATI |
| Market Cap: | 6.4B | IPO Year: | N/A |
| Target Price: | $578.50 | AVG Volume (30 days): | 192.8K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 4 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 19.48 | EPS Growth: | -1.23 |
| 52 Week Low/High: | $408.42 - $623.61 | Next Earning Date: | 10-28-2025 |
| Revenue: | $2,511,915,000 | Revenue Growth: | 7.55% |
| Revenue Growth (this year): | 5.91% | Revenue Growth (next year): | 6.72% |
Stock Insider Trading Activity of Chemed Corp (CHE)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| MCNAMARA KEVIN J | CHE | president and CEO | Sep 26 '25 | Sell | $461.28 | 3,000 | $1,383,840.00 | 96,197 | |
| GRACE PATRICK P | CHE | Director | Sep 9 '25 | Sell | $463.39 | 150 | $69,508.50 | 3,397 |
Latest Chemed Corp News
CHE Breaking Stock News: Dive into CHE Ticker-Specific Updates for Smart Investing
Business Wire
a month ago
Chemed To Report Third-Quarter 2025 Earnings October 28, Related Conference Call To Be Held On October 29
Insider Monkey
a month ago
Chemed Corporation (CHE): A Bull Case Theory
Argus Research
4 months ago
CHE: Raising target price to $613.00
StockStory
4 months ago
5 Must-Read Analyst Questions From Chemed’s Q1 Earnings Call
StockStory
5 months ago
1 Cash-Producing Stock Worth Your Attention and 2 to Brush Off
Argus Research
5 months ago
CHE: Lowering target price to $609.00
StockStory
5 months ago
Senior Health, Home Health & Hospice Stocks Q1 In Review: Chemed (NYSE:CHE) Vs Peers
StockStory
5 months ago
3 Reasons CHE is Risky and 1 Stock to Buy Instead
Compare CHE vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CHE Chemed Corp - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.